CONMED Corporation
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.4% | -4.5% | +6.3% | -4.6% | +9.2% | -7.7% | +7.4% | -1.3% | +10.3% | -15.1% | +8.3% | – | |
| – | +6.1% | -3.1% | +5.7% | -7.2% | +7.2% | +2.7% | +7.3% | +11.1% | -11.3% | -16.6% | +9.3% | – | |
| – | +8.4% | -5.6% | +6.8% | -2.6% | +10.8% | -15.4% | +7.5% | -12.5% | +35.1% | -14.0% | +7.6% | – | |
| – | +12.5% | -3.1% | +3.7% | -3.8% | -2.8% | -1.7% | +9.2% | -1.7% | +7.2% | +9.6% | -5.1% | – | |
| – | -5.9% | +4.6% | -0.7% | -18.6% | +33.0% | +12.2% | -18.8% | +1.0% | +36.6% | -15.0% | +2.7% | – | |
| – | -4.2% | +3.8% | -0.2% | -17.1% | +28.7% | +7.2% | -11.3% | -0.2% | +5.7% | +7.9% | +1.9% | – | |
| – | +65.6% | -30.2% | +34.5% | +39.5% | -20.1% | -78.1% | +263.4% | -53.5% | +244.7% | -62.0% | +43.2% | – | |
| – | -5.1% | +0.9% | 0.0% | -3.6% | -4.3% | -6.4% | -5.6% | -2.8% | -3.1% | -4.2% | +11.7% | – | |
| – | +100.6% | -37.5% | +47.6% | +50.5% | -22.7% | -82.4% | +290.0% | -85.7% | +584.6% | -37.3% | +70.8% | – | |
| – | +71.3% | -25.0% | +32.0% | -0.9% | +32.3% | -83.5% | +419.4% | -83.4% | +785.0% | -63.8% | +82.8% | – | |
| – | +108.8% | -40.4% | +52.1% | +63.4% | -31.1% | -82.1% | +254.9% | -86.7% | +485.5% | -17.4% | +66.8% | – | |
| – | +58.9% | -22.2% | +22.4% | +28.8% | -15.7% | -59.0% | +76.2% | -51.0% | +122.3% | -31.0% | +60.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.